A COMPARISON OF DOPAMINE RECEPTOR BLOCKING ASSAY WITH PLASMA DRUG LEVELS OF HALOPERIDOL IN SCHIZOPHRENIC-PATIENTS

被引：16
|
作者：
KURLAND, AA [1 ]
NAGARAJU, A [1 ]
HANLON, TE [1 ]
WILKINSON, EH [1 ]
NG, KT [1 ]
机构：
[1] MCNEIL LABS INC,FT WASHINGTON,PA 19034
来源：
JOURNAL OF CLINICAL PHARMACOLOGY | 1981年 / 21卷 / 01期
关键词：
D O I：
10.1002/j.1552-4604.1981.tb01731.x
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：42 / 47
页数：6
相关论文
共 50 条
  • [41] EXPERIMENTAL COMPARISON OF LOW AND HIGH-DOSES OF HALOPERIDOL IN THE TREATMENT OF ACUTELY SCHIZOPHRENIC-PATIENTS
    TEGELER, J
    LEHMANN, E
    QUADBECK, H
    KLIESER, E
    WOLLER, W
    ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1982, 32-2 (08): : 887 - 888
  • [42] THE DOPAMINE HYPOTHESIS - AN OVERVIEW OF STUDIES WITH SCHIZOPHRENIC-PATIENTS
    HARACZ, JL
    SCHIZOPHRENIA BULLETIN, 1982, 8 (03) : 438 - 469
  • [43] IS DOPAMINE RELATED TO IMMUNOLOGICAL CHANGES IN SCHIZOPHRENIC-PATIENTS
    KEREPCIC, I
    BAMBURAC, J
    JURIN, M
    ANNALS OF THE NEW YORK ACADEMY OF SCIENCES-SERIES, 1987, 496 : 737 - 739
  • [44] DRUG LEVELS AND ANTIPARKINSONIAN DRUGS IN NEUROLEPTIC-TREATED SCHIZOPHRENIC-PATIENTS
    HITRI, A
    CRAFT, RB
    SETHI, R
    SINHA, D
    CLINICAL NEUROPHARMACOLOGY, 1987, 10 (03) : 261 - 271
  • [45] Lower plasma levels of haloperidol in smoking than in nonsmoking schizophrenic patients
    Shimoda, K
    Someya, T
    Morita, S
    Hirokane, G
    Noguchi, G
    Yokono, A
    Shibasaki, M
    Takahashi, S
    THERAPEUTIC DRUG MONITORING, 1999, 21 (03) : 293 - 296
  • [46] Biperiden and haloperidol plasma levels and extrapyramidal side effects in schizophrenic patients
    Meszaros, K
    Lenzinger, E
    Hornik, K
    Schonbeck, G
    Hatzinger, R
    Langer, G
    Sieghart, W
    Aschauer, HN
    NEUROPSYCHOBIOLOGY, 1997, 36 (02) : 69 - 72
  • [47] PLASMA-LEVELS OF NEUROLEPTIC DRUGS AND EXTRAPYRAMIDAL SYMPTOMS IN SCHIZOPHRENIC-PATIENTS
    BLOEINK, M
    BERGENER, M
    HESSE, C
    INTERNATIONAL JOURNAL OF NEUROSCIENCE, 1987, 32 (1-2) : 833 - 833
  • [48] PLASMA-LEVELS AND DOSING STRATEGIES IN SCHIZOPHRENIC-PATIENTS RECEIVING CLOZAPINE
    BUCKLEY, PF
    COLA, PA
    HASEGAWA, N
    LYS, C
    MELTZER, HY
    SCHIZOPHRENIA RESEARCH, 1995, 15 (1-2) : 144 - 145
  • [49] DIFFERENTIAL-EFFECTS OF HALOPERIDOL ON NEGATIVE SYMPTOMS IN DRUG-NAIVE SCHIZOPHRENIC-PATIENTS - EFFECTS ON PLASMA HOMOVANILLIC-ACID
    LABARCA, R
    SILVA, H
    JEREZ, S
    RUIZ, A
    FORRAY, MI
    GYSLING, K
    ANDRES, ME
    BUSTOS, G
    CASTILLO, Y
    HONO, J
    SCHIZOPHRENIA RESEARCH, 1993, 9 (01) : 29 - 34
  • [50] DRUG DEFAULT AMONG SCHIZOPHRENIC-PATIENTS
    NELSON, AA
    GOLD, BH
    HUTCHINSON, RA
    BENEZRA, E
    AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1975, 32 (12): : 1237 - 1242
12345